ZK824190 hydrochloride is an orally available and selective urokinase plasminogen activator ( uPA ) inhibitor as a potential treatment for multiple sclerosis. IC 50 s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively.
In Vivo
ZK824190 (2 mg/kg; PO; Rats with EAE model) exhibits a relatively high oral availability and a moderate half time (T 1/2 =2.8 h) . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
规格
别名
ZK824190 盐酸盐
规格或纯度
≥99%
英文名称
ZK824190 hydrochloride
生化机理
ZK824190 盐酸盐是一种口服选择性尿激酶纤溶酶原激活剂(uPA)抑制剂,可用于治疗多发性硬化症。对 uPA、tPA 和 Plasmin 的 IC 50 s 分别为 237、1600 和 1850 nM。